Cytosorbents (CTSO) Misses Q1 EPS by 4c

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $9.4 million versus the consensus estimate of $8.6 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings
• Deere shares climb as fiscal Q3 earnings and revenue top estimates